Susan M. Buttler

488 total citations
9 papers, 405 citations indexed

About

Susan M. Buttler is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Psychiatry and Mental health. According to data from OpenAlex, Susan M. Buttler has authored 9 papers receiving a total of 405 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Endocrinology, Diabetes and Metabolism, 7 papers in Surgery and 2 papers in Psychiatry and Mental health. Recurrent topics in Susan M. Buttler's work include Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Hormonal and reproductive studies (2 papers). Susan M. Buttler is often cited by papers focused on Lipoproteins and Cardiovascular Health (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (5 papers) and Hormonal and reproductive studies (2 papers). Susan M. Buttler collaborates with scholars based in United States and Canada. Susan M. Buttler's co-authors include Maureen T. Kelly, Carolyn M. Setze, Darryl J. Sleep, James C. Stolzenbach, Peter H. Jones, Anthony Edmonds, Michael H. Davidson, Harold Bays, Syed M. Mohiuddin and Janet O’Neil and has published in prestigious journals such as The American Journal of Cardiology, American Heart Journal and Atherosclerosis.

In The Last Decade

Susan M. Buttler

9 papers receiving 393 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susan M. Buttler United States 8 278 265 88 86 48 9 405
Jeanne M. Dobrzynski United States 7 100 0.4× 159 0.6× 44 0.5× 26 0.3× 103 2.1× 14 354
José M. Mostaza Spain 14 85 0.3× 197 0.7× 50 0.6× 12 0.1× 117 2.4× 30 369
G.M. Lindsay United Kingdom 10 336 1.2× 347 1.3× 7 0.1× 105 1.2× 187 3.9× 12 645
Aditi Parulkar United States 2 292 1.1× 54 0.2× 117 1.3× 9 0.1× 100 2.1× 5 502
Jacqueline Honerlaw United States 8 53 0.2× 110 0.4× 11 0.1× 16 0.2× 72 1.5× 19 301
Kathleen Berra United States 5 138 0.5× 178 0.7× 7 0.1× 36 0.4× 192 4.0× 7 399
Konstantinos Koutsampasopoulos Greece 7 148 0.5× 60 0.2× 32 0.4× 9 0.1× 66 1.4× 18 324
Olaf H. Klungel Netherlands 9 47 0.2× 85 0.3× 12 0.1× 17 0.2× 37 0.8× 13 379
Mark Kolasa United States 7 122 0.4× 156 0.6× 4 0.0× 36 0.4× 128 2.7× 12 322
Margarida Borges Portugal 6 150 0.5× 136 0.5× 7 0.1× 19 0.2× 50 1.0× 8 282

Countries citing papers authored by Susan M. Buttler

Since Specialization
Citations

This map shows the geographic impact of Susan M. Buttler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susan M. Buttler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susan M. Buttler more than expected).

Fields of papers citing papers by Susan M. Buttler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susan M. Buttler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susan M. Buttler. The network helps show where Susan M. Buttler may publish in the future.

Co-authorship network of co-authors of Susan M. Buttler

This figure shows the co-authorship network connecting the top 25 collaborators of Susan M. Buttler. A scholar is included among the top collaborators of Susan M. Buttler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susan M. Buttler. Susan M. Buttler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Jones, Peter H., Michael H. Davidson, Anne C. Goldberg, et al.. (2009). Efficacy and safety of fenofibric acid in combination with a statin in patients with mixed dyslipidemia: Pooled analysis of three phase 3, 12-week randomized, controlled studies. Journal of clinical lipidology. 3(2). 125–137. 17 indexed citations
2.
Goldberg, Anne C., Harold Bays, Christie M. Ballantyne, et al.. (2008). Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination With Atorvastatin in Patients With Mixed Dyslipidemia. The American Journal of Cardiology. 103(4). 515–522. 58 indexed citations
3.
Jones, Peter H., Harold Bays, Michael H. Davidson, et al.. (2008). Evaluation of a New Formulation of Fenofibric Acid, ABT-335, Co-Administered with Statins. Clinical Drug Investigation. 28(10). 625–634. 34 indexed citations
4.
Bays, Harold, Peter H. Jones, Syed M. Mohiuddin, et al.. (2008). Long-term safety and efficacy of fenofibric acid in combination with statin therapy for the treatment of patients with mixed dyslipidemia. Journal of clinical lipidology. 2(6). 426–435. 44 indexed citations
5.
Jones, Peter H., Michael H. Davidson, Moti L. Kashyap, et al.. (2008). Efficacy and safety of ABT-335 (fenofibric acid) in combination with rosuvastatin in patients with mixed dyslipidemia: A phase 3 study. Atherosclerosis. 204(1). 208–215. 80 indexed citations
6.
Mohiuddin, Syed M., Carl J. Pepine, Maureen T. Kelly, et al.. (2008). Efficacy and safety of ABT-335 (fenofibric acid) in combination with simvastatin in patients with mixed dyslipidemia: A phase 3, randomized, controlled study. American Heart Journal. 157(1). 195–203. 66 indexed citations
7.
Jones, Peter H., Susan M. Buttler, Michael H. Davidson, et al.. (2008). 214: Efficacy and Safety of ABT-335 (Fenofibric Acid) in Combination with Rosuvastatin in Patients with Mixed Dyslipidemia: A Phase 3 Study. Journal of clinical lipidology. 2(3). 218–219. 1 indexed citations
8.
Fagan, Timothy C., Susan M. Buttler, Thomas Marbury, Addison A. Taylor, & Anthony Edmonds. (2001). Cardiovascular safety of sublingual apomorphine in patients on stable doses of oral antihypertensive agents and nitrates. The American Journal of Cardiology. 88(7). 760–766. 27 indexed citations
9.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeanne M. Dobrzynski Breakdown of academic impact, for papers by José M. Mostaza Breakdown of academic impact, for papers by G.M. Lindsay Breakdown of academic impact, for papers by Aditi Parulkar Breakdown of academic impact, for papers by Jacqueline Honerlaw Breakdown of academic impact, for papers by Kathleen Berra Breakdown of academic impact, for papers by Konstantinos Koutsampasopoulos Breakdown of academic impact, for papers by Olaf H. Klungel Breakdown of academic impact, for papers by Mark Kolasa Breakdown of academic impact, for papers by Margarida Borges
Rankless by CCL
2026